Original article: http://www.sciencedaily.com/releases/2014/10/141022123021.htm
Some key words:
Neurodegenerative diseases: Disease such as Alzheimer’s, Parkinson’s and Huntington’s disease that undergo a neurodegenerative process, specific neurons are targeted for degeneration.
Spiny brain cell: The desired end brain cell in this study, and a brain cell affected by Huntington’s disease
In a study by the researchers at Washington University School of Medicine in Saint Louis, they demonstrate a way for human skin cells to be specifically converted to a type of brain cell. This study can help in the rehabilitation of people with Huntington’s disease by turning skin cells in to brain cells that are lost through this neurodegenerative disease. This is all accomplished without passing through the stem cell phase preventing other cell types forming.
This research involved adult skin cells that Yoo, the senior author, and his colleagues reprogrammed by using two microRNAs: miR-9, and miR-124. These micro RNAs open up the otherwise tightly packaged and inactive sections of the gene critical to the formation of brain cells. While the micro RNAs open up genes used for the creation and functionality of neurons, transcription factors taken from a part of the brain where medium spiny neurons are common directs the newly formed brain cells to a specific subunit of brain cells. The researchers then observed that the newly formed brain cells behave and function in a similar way to the native medium spiny neurons in mice, allowing this study to proceed in to further stages of experimentation, and hopefully result in a treatment practical for human use.
This study is very critical in the advancement of the treatment for neurodegenerative disease such as Huntington’s disease. Using different transcription factors from parts of the brain, alternate types of brain cells can be created to replace cells lost from neurodegenerative effects. This form of treatment will also prevent rejection of the transplant because the skin cells can be taken from the patient’s own body. This is a breakthrough in our pursuit of cures for these lethal neurodegenerative diseases.